image
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 3.47
-3.61 %
$ 279 M
Market Cap
-3.4
P/E
1. INTRINSIC VALUE

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.[ Read More ]

The intrinsic value of one ACCD stock under the base case scenario is HIDDEN Compared to the current market price of 3.47 USD, Accolade, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ACCD

image
FINANCIALS
414 M REVENUE
14.09%
-114 M OPERATING INCOME
-84.22%
-99.8 M NET INCOME
78.29%
-16.2 M OPERATING CASH FLOW
60.28%
-63.6 M INVESTING CASH FLOW
-780.31%
-55.6 M FINANCING CASH FLOW
-1756.78%
106 M REVENUE
-3.72%
-25.1 M OPERATING INCOME
13.44%
-23.9 M NET INCOME
13.26%
4.14 M OPERATING CASH FLOW
158.20%
-19.5 M INVESTING CASH FLOW
-243.00%
11 K FINANCING CASH FLOW
-99.47%
Balance Sheet Decomposition Accolade, Inc.
image
Current Assets 281 M
Cash & Short-Term Investments 237 M
Receivables 27.7 M
Other Current Assets 15.8 M
Non-Current Assets 508 M
Long-Term Investments 0
PP&E 47.5 M
Other Non-Current Assets 460 M
Current Liabilities 108 M
Accounts Payable 13.7 M
Short-Term Debt 7.09 M
Other Current Liabilities 87 M
Non-Current Liabilities 235 M
Long-Term Debt 235 M
Other Non-Current Liabilities 277 K
EFFICIENCY
Earnings Waterfall Accolade, Inc.
image
Revenue 414 M
Cost Of Revenue 271 M
Gross Profit 144 M
Operating Expenses 307 M
Operating Income -114 M
Other Expenses -14.6 M
Net Income -99.8 M
RATIOS
34.67% GROSS MARGIN
34.67%
-27.63% OPERATING MARGIN
-27.63%
-24.09% NET MARGIN
-24.09%
-22.40% ROE
-22.40%
-12.66% ROA
-12.66%
-17.71% ROIC
-17.71%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Accolade, Inc.
image
Net Income -99.8 M
Depreciation & Amortization 45.2 M
Capital Expenditures -12.5 M
Stock-Based Compensation 60.9 M
Change in Working Capital -20 M
Others -24.8 M
Free Cash Flow -28.7 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Accolade, Inc.
image
Wall Street analysts predict an average 1-year price target for ACCD of $8.36 , with forecasts ranging from a low of $5 to a high of $13 .
ACCD Lowest Price Target Wall Street Target
5 USD 44.09%
ACCD Average Price Target Wall Street Target
8.36 USD 140.84%
ACCD Highest Price Target Wall Street Target
13 USD 274.64%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Accolade, Inc.
image
Sold
0-3 MONTHS
56.3 K USD 5
3-6 MONTHS
306 K USD 5
6-9 MONTHS
95.9 K USD 5
9-12 MONTHS
1.98 M USD 5
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
5 days ago
Nov 12, 2024
Sell 2.43 K USD
SINGH RAJEEV
Chief Executive Officer
- 668
3.638 USD
5 days ago
Nov 12, 2024
Sell 811 USD
Barnes Stephen H.
Chief Financial Officer
- 223
3.638 USD
5 days ago
Nov 12, 2024
Sell 779 USD
Cavanaugh Robert N
President
- 214
3.638 USD
1 week ago
Nov 04, 2024
Sell 1.44 K USD
Barnes Stephen H.
Chief Financial Officer
- 458
3.149 USD
1 week ago
Nov 04, 2024
Sell 1.5 K USD
Cavanaugh Robert N
President
- 475
3.149 USD
1 week ago
Nov 04, 2024
Sell 4.87 K USD
SINGH RAJEEV
Chief Executive Officer
- 1545
3.149 USD
1 week ago
Nov 04, 2024
Sell 1.06 K USD
Eskew Richard
EVP General Counsel
- 336
3.149 USD
1 week ago
Nov 04, 2024
Sell 1.41 K USD
McHugh Colin
Chief Accounting Officer
- 448
3.149 USD
1 month ago
Oct 17, 2024
Sell 1.41 K USD
SINGH RAJEEV
Chief Executive Officer
- 385
3.669 USD
1 month ago
Oct 17, 2024
Sell 576 USD
Cavanaugh Robert N
President
- 157
3.669 USD
1 month ago
Oct 17, 2024
Sell 448 USD
Barnes Stephen H.
Chief Financial Officer
- 122
3.669 USD
1 month ago
Oct 11, 2024
Sell 860 USD
Barnes Stephen H.
Chief Financial Officer
- 228
3.771 USD
1 month ago
Oct 11, 2024
Sell 818 USD
Cavanaugh Robert N
President
- 217
3.771 USD
1 month ago
Oct 11, 2024
Sell 2.56 K USD
SINGH RAJEEV
Chief Executive Officer
- 680
3.771 USD
1 month ago
Oct 02, 2024
Sell 1.66 K USD
McHugh Colin
Chief Accounting Officer
- 448
3.704 USD
1 month ago
Oct 02, 2024
Sell 1.69 K USD
Barnes Stephen H.
Chief Financial Officer
- 456
3.704 USD
1 month ago
Oct 02, 2024
Sell 1.24 K USD
Eskew Richard
EVP General Counsel
- 334
3.704 USD
1 month ago
Oct 02, 2024
Sell 1.76 K USD
Cavanaugh Robert N
President
- 474
3.704 USD
1 month ago
Oct 02, 2024
Sell 5.7 K USD
SINGH RAJEEV
Chief Executive Officer
- 1540
3.704 USD
2 months ago
Sep 17, 2024
Sell 1.58 K USD
SINGH RAJEEV
Chief Executive Officer
- 366
4.318 USD
2 months ago
Sep 17, 2024
Sell 643 USD
Cavanaugh Robert N
President
- 149
4.318 USD
2 months ago
Sep 17, 2024
Sell 505 USD
Barnes Stephen H.
Chief Financial Officer
- 117
4.318 USD
2 months ago
Sep 11, 2024
Sell 2.63 K USD
SINGH RAJEEV
Chief Executive Officer
- 672
3.911 USD
2 months ago
Sep 11, 2024
Sell 880 USD
Barnes Stephen H.
Chief Financial Officer
- 225
3.911 USD
2 months ago
Sep 11, 2024
Sell 841 USD
Cavanaugh Robert N
President
- 215
3.911 USD
2 months ago
Sep 04, 2024
Sell 6.45 K USD
SINGH RAJEEV
Chief Executive Officer
- 1527
4.224 USD
2 months ago
Sep 04, 2024
Sell 1.99 K USD
Cavanaugh Robert N
President
- 470
4.224 USD
2 months ago
Sep 04, 2024
Sell 1.91 K USD
Barnes Stephen H.
Chief Financial Officer
- 452
4.224 USD
2 months ago
Sep 04, 2024
Sell 1.4 K USD
Eskew Richard
EVP General Counsel
- 331
4.224 USD
2 months ago
Sep 04, 2024
Sell 1.82 K USD
McHugh Colin
Chief Accounting Officer
- 430
4.224 USD
2 months ago
Aug 19, 2024
Sell 493 USD
Barnes Stephen H.
Chief Financial Officer
- 119
4.145 USD
2 months ago
Aug 19, 2024
Sell 634 USD
Cavanaugh Robert N
President
- 153
4.145 USD
2 months ago
Aug 19, 2024
Sell 1.55 K USD
SINGH RAJEEV
Chief Executive Officer
- 373
4.145 USD
3 months ago
Aug 13, 2024
Sell 830 USD
Cavanaugh Robert N
President
- 213
3.897 USD
3 months ago
Aug 13, 2024
Sell 861 USD
Barnes Stephen H.
Chief Financial Officer
- 221
3.897 USD
3 months ago
Aug 13, 2024
Sell 2.58 K USD
SINGH RAJEEV
Chief Executive Officer
- 662
3.897 USD
3 months ago
Aug 02, 2024
Sell 1.74 K USD
McHugh Colin
Chief Accounting Officer
- 470
3.709 USD
3 months ago
Aug 02, 2024
Sell 1.82 K USD
Cavanaugh Robert N
President
- 491
3.709 USD
3 months ago
Aug 02, 2024
Sell 1.74 K USD
Barnes Stephen H.
Chief Financial Officer
- 470
3.709 USD
3 months ago
Aug 02, 2024
Sell 1.28 K USD
Eskew Richard
EVP General Counsel
- 345
3.709 USD
3 months ago
Aug 02, 2024
Sell 5.9 K USD
SINGH RAJEEV
Chief Executive Officer
- 1590
3.709 USD
4 months ago
Jul 17, 2024
Sell 606 USD
Cavanaugh Robert N
President
- 157
3.857 USD
4 months ago
Jul 17, 2024
Sell 1.48 K USD
SINGH RAJEEV
Chief Executive Officer
- 383
3.857 USD
4 months ago
Jul 17, 2024
Sell 471 USD
Barnes Stephen H.
Chief Financial Officer
- 122
3.857 USD
4 months ago
Jul 11, 2024
Sell 771 USD
Barnes Stephen H.
Chief Financial Officer
- 219
3.521 USD
4 months ago
Jul 11, 2024
Sell 2.29 K USD
SINGH RAJEEV
Chief Executive Officer
- 649
3.521 USD
4 months ago
Jul 11, 2024
Sell 732 USD
Cavanaugh Robert N
President
- 208
3.521 USD
4 months ago
Jul 02, 2024
Sell 1.54 K USD
Barnes Stephen H.
Chief Financial Officer
- 436
3.541 USD
4 months ago
Jul 02, 2024
Sell 1.62 K USD
Cavanaugh Robert N
President
- 457
3.541 USD
4 months ago
Jul 02, 2024
Sell 5.37 K USD
SINGH RAJEEV
Chief Executive Officer
- 1517
3.541 USD
4 months ago
Jul 02, 2024
Sell 1.22 K USD
Eskew Richard
EVP General Counsel
- 345
3.541 USD
4 months ago
Jul 02, 2024
Sell 1.85 K USD
McHugh Colin
Chief Accounting Officer
- 523
3.541 USD
5 months ago
Jun 18, 2024
Sell 950 USD
Cavanaugh Robert N
President
- 155
6.129 USD
5 months ago
Jun 18, 2024
Sell 742 USD
Barnes Stephen H.
Chief Financial Officer
- 121
6.129 USD
5 months ago
Jun 18, 2024
Sell 2.32 K USD
SINGH RAJEEV
Chief Executive Officer
- 379
6.129 USD
5 months ago
Jun 12, 2024
Sell 36.3 K USD
Barnes Stephen H.
Chief Financial Officer
- 5482
6.615 USD
5 months ago
Jun 12, 2024
Sell 21.4 K USD
Eskew Richard
EVP General Counsel
- 3229
6.615 USD
5 months ago
Jun 12, 2024
Sell 36.7 K USD
McHugh Colin
Chief Accounting Officer
- 5543
6.615 USD
5 months ago
Jun 12, 2024
Sell 37.9 K USD
Cavanaugh Robert N
President
- 5728
6.615 USD
5 months ago
Jun 12, 2024
Sell 123 K USD
SINGH RAJEEV
Chief Executive Officer
- 18617
6.615 USD
5 months ago
Jun 11, 2024
Sell 1.44 K USD
Cavanaugh Robert N
President
- 223
6.449 USD
5 months ago
Jun 11, 2024
Sell 4.45 K USD
SINGH RAJEEV
Chief Executive Officer
- 690
6.449 USD
5 months ago
Jun 11, 2024
Sell 1.49 K USD
Barnes Stephen H.
Chief Financial Officer
- 231
6.449 USD
6 months ago
May 17, 2024
Sell 880 USD
Barnes Stephen H.
Chief Financial Officer
- 121
7.273 USD
6 months ago
May 17, 2024
Sell 1.12 K USD
Cavanaugh Robert N
President
- 154
7.273 USD
6 months ago
May 17, 2024
Sell 2.73 K USD
SINGH RAJEEV
Chief Executive Officer
- 376
7.273 USD
6 months ago
May 13, 2024
Sell 1.59 K USD
Barnes Stephen H.
Chief Financial Officer
- 214
7.444 USD
6 months ago
May 13, 2024
Sell 1.53 K USD
Cavanaugh Robert N
President
- 206
7.444 USD
6 months ago
May 13, 2024
Sell 4.76 K USD
SINGH RAJEEV
Chief Executive Officer
- 640
7.444 USD
6 months ago
May 02, 2024
Sell 3.09 K USD
McHugh Colin
Chief Accounting Officer
- 424
7.281 USD
6 months ago
May 02, 2024
Sell 3.36 K USD
Eskew Richard
EVP General Counsel
- 462
7.281 USD
7 months ago
Apr 18, 2024
Sell 962 USD
Barnes Stephen H.
Chief Financial Officer
- 109
8.823 USD
7 months ago
Apr 18, 2024
Sell 1.24 K USD
Cavanaugh Robert N
President
- 141
8.823 USD
7 months ago
Apr 18, 2024
Sell 3.13 K USD
SINGH RAJEEV
Chief Executive Officer
- 355
8.823 USD
7 months ago
Apr 11, 2024
Sell 2.24 K USD
Cavanaugh Robert N
President
- 253
8.849 USD
7 months ago
Apr 11, 2024
Sell 2.34 K USD
Barnes Stephen H.
Chief Financial Officer
- 265
8.849 USD
7 months ago
Apr 11, 2024
Sell 5.9 K USD
SINGH RAJEEV
Chief Executive Officer
- 667
8.849 USD
7 months ago
Apr 02, 2024
Sell 5.62 K USD
Eskew Richard
EVP General Counsel
- 587
9.582 USD
7 months ago
Apr 02, 2024
Sell 4.24 K USD
McHugh Colin
Chief Accounting Officer
- 443
9.582 USD
7 months ago
Mar 19, 2024
Sell 1.13 K USD
Barnes Stephen H.
Chief Financial Officer
- 119
9.484 USD
7 months ago
Mar 19, 2024
Sell 1.72 K USD
Cavanaugh Robert N
President
- 181
9.484 USD
7 months ago
Mar 19, 2024
Sell 3.57 K USD
SINGH RAJEEV
Chief Executive Officer
- 376
9.484 USD
8 months ago
Mar 12, 2024
Sell 2.11 K USD
Barnes Stephen H.
Chief Financial Officer
- 222
9.524 USD
8 months ago
Mar 12, 2024
Sell 2.4 K USD
Cavanaugh Robert N
President
- 252
9.524 USD
8 months ago
Mar 12, 2024
Sell 6.3 K USD
SINGH RAJEEV
Chief Executive Officer
- 662
9.524 USD
8 months ago
Mar 04, 2024
Sell 4.17 K USD
McHugh Colin
Chief Accounting Officer
- 433
9.635 USD
8 months ago
Mar 04, 2024
Sell 4.67 K USD
Eskew Richard
EVP General Counsel
- 485
9.635 USD
8 months ago
Feb 20, 2024
Sell 1.74 K USD
Barnes Stephen H.
Chief Financial Officer
- 145
11.986 USD
8 months ago
Feb 20, 2024
Sell 4.63 K USD
SINGH RAJEEV
Chief Executive Officer
- 386
11.986 USD
8 months ago
Feb 20, 2024
Sell 2.23 K USD
Cavanaugh Robert N
President
- 186
11.986 USD
8 months ago
Feb 20, 2024
Sell 4.84 K USD
Eskew Richard
EVP General Counsel
- 400
12.09 USD
9 months ago
Feb 13, 2024
Sell 3.49 K USD
Cavanaugh Robert N
President
- 268
13.028 USD
9 months ago
Feb 13, 2024
Sell 3.63 K USD
Barnes Stephen H.
Chief Financial Officer
- 279
13.028 USD
9 months ago
Feb 13, 2024
Sell 9.18 K USD
SINGH RAJEEV
Chief Executive Officer
- 705
13.028 USD
9 months ago
Feb 02, 2024
Sell 6.51 K USD
Eskew Richard
EVP General Counsel
- 562
11.591 USD
9 months ago
Feb 02, 2024
Sell 4.91 K USD
McHugh Colin
Chief Accounting Officer
- 424
11.591 USD
9 months ago
Jan 19, 2024
Sell 4.8 K USD
Eskew Richard
EVP General Counsel
- 400
11.99 USD
10 months ago
Jan 17, 2024
Sell 2.39 K USD
Cavanaugh Robert N
President
- 186
12.862 USD
10 months ago
Jan 17, 2024
Sell 4.93 K USD
SINGH RAJEEV
Chief Executive Officer
- 383
12.862 USD
10 months ago
Jan 17, 2024
Sell 1.88 K USD
Barnes Stephen H.
Chief Financial Officer
- 146
12.862 USD
10 months ago
Jan 11, 2024
Sell 323 K USD
SINGH RAJEEV
Chief Executive Officer
- 21530
15.0221 USD
10 months ago
Jan 11, 2024
Sell 11.4 K USD
SINGH RAJEEV
Chief Executive Officer
- 770
14.745 USD
10 months ago
Jan 11, 2024
Sell 3.76 K USD
Cavanaugh Robert N
President
- 255
14.745 USD
10 months ago
Jan 11, 2024
Sell 3.94 K USD
Barnes Stephen H.
Chief Financial Officer
- 267
14.745 USD
10 months ago
Jan 10, 2024
Sell 1.01 M USD
SINGH RAJEEV
Chief Executive Officer
- 67271
15.034 USD
10 months ago
Jan 09, 2024
Sell 543 K USD
SINGH RAJEEV
Chief Executive Officer
- 36199
15.0046 USD
10 months ago
Jan 03, 2024
Sell 6.73 K USD
Eskew Richard
EVP General Counsel
- 590
11.402 USD
10 months ago
Jan 03, 2024
Sell 5.09 K USD
McHugh Colin
Chief Accounting Officer
- 446
11.402 USD
10 months ago
Dec 19, 2023
Sell 1.26 K USD
Barnes Stephen H.
Chief Financial Officer
- 116
10.892 USD
10 months ago
Dec 19, 2023
Sell 1.64 K USD
Cavanaugh Robert N
President
- 151
10.892 USD
10 months ago
Dec 19, 2023
Sell 3.99 K USD
SINGH RAJEEV
Chief Executive Officer
- 366
10.892 USD
10 months ago
Dec 19, 2023
Sell 4.3 K USD
Eskew Richard
EVP General Counsel
- 400
10.76 USD
11 months ago
Dec 12, 2023
Sell 6.25 K USD
SINGH RAJEEV
Chief Executive Officer
- 677
9.23 USD
11 months ago
Dec 12, 2023
Sell 2.09 K USD
Barnes Stephen H.
Chief Financial Officer
- 226
9.23 USD
11 months ago
Dec 12, 2023
Sell 2.04 K USD
Cavanaugh Robert N
President
- 221
9.23 USD
11 months ago
Dec 04, 2023
Sell 4.24 K USD
Eskew Richard
EVP General Counsel
- 468
9.07 USD
11 months ago
Dec 04, 2023
Sell 3.2 K USD
McHugh Colin
Chief Accounting Officer
- 353
9.07 USD
1 year ago
Nov 17, 2023
Sell 1.18 K USD
Cavanaugh Robert N
President
- 149
7.942 USD
1 year ago
Nov 17, 2023
Sell 2.84 K USD
SINGH RAJEEV
Chief Executive Officer
- 358
7.942 USD
1 year ago
Nov 17, 2023
Sell 905 USD
Barnes Stephen H.
Chief Financial Officer
- 114
7.942 USD
1 year ago
Nov 13, 2023
Sell 1.56 K USD
Barnes Stephen H.
Chief Financial Officer
- 223
6.9935 USD
1 year ago
Nov 13, 2023
Sell 1.52 K USD
Cavanaugh Robert N
President
- 217
6.9935 USD
1 year ago
Nov 13, 2023
Sell 4.66 K USD
SINGH RAJEEV
Chief Executive Officer
- 666
6.9935 USD
1 year ago
Nov 02, 2023
Sell 3.14 K USD
Eskew Richard
EVP General Counsel
- 456
6.882 USD
1 year ago
Nov 02, 2023
Sell 2.37 K USD
McHugh Colin
Chief Accounting Officer
- 345
6.882 USD
1 year ago
Oct 17, 2023
Sell 852 USD
Barnes Stephen H.
Chief Financial Officer
- 118
7.218 USD
1 year ago
Oct 17, 2023
Sell 1.1 K USD
Cavanaugh Robert N
President
- 153
7.218 USD
1 year ago
Oct 17, 2023
Sell 2.68 K USD
SINGH RAJEEV
Chief Executive Officer
- 371
7.218 USD
1 year ago
Oct 11, 2023
Sell 5.69 K USD
SINGH RAJEEV
Chief Executive Officer
- 659
8.627 USD
1 year ago
Oct 11, 2023
Sell 1.85 K USD
Cavanaugh Robert N
President
- 214
8.627 USD
1 year ago
Oct 11, 2023
Sell 1.9 K USD
Barnes Stephen H.
Chief Financial Officer
- 220
8.627 USD
1 year ago
Oct 03, 2023
Sell 4.91 K USD
Eskew Richard
EVP General Counsel
- 485
10.125 USD
1 year ago
Oct 03, 2023
Sell 3.71 K USD
McHugh Colin
Chief Accounting Officer
- 366
10.125 USD
1 year ago
Sep 19, 2023
Sell 1.85 K USD
Cavanaugh Robert N
President
- 157
11.81 USD
1 year ago
Sep 19, 2023
Sell 1.43 K USD
Barnes Stephen H.
Chief Financial Officer
- 121
11.81 USD
1 year ago
Sep 19, 2023
Sell 4.46 K USD
SINGH RAJEEV
Chief Executive Officer
- 378
11.81 USD
1 year ago
Sep 12, 2023
Sell 2.84 K USD
Cavanaugh Robert N
President
- 215
13.227 USD
1 year ago
Sep 12, 2023
Sell 8.76 K USD
SINGH RAJEEV
Chief Executive Officer
- 662
13.227 USD
1 year ago
Sep 12, 2023
Sell 2.92 K USD
Barnes Stephen H.
Chief Financial Officer
- 221
13.227 USD
1 year ago
Sep 05, 2023
Sell 6.43 K USD
Eskew Richard
EVP General Counsel
- 475
13.534 USD
1 year ago
Sep 05, 2023
Sell 4.85 K USD
McHugh Colin
Chief Accounting Officer
- 358
13.534 USD
7. News
Accolade To Present at Upcoming Investor Conferences SEATTLE, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor events. A webcast will be available at ir.accolade.com and a replay will be available for 90 days. globenewswire.com - 3 days ago
Porter Airlines Receives Another Accolade with APEX Four Star Major Airline Rating TORONTO--(BUSINESS WIRE)--Porter Airlines has been rated a 2025 Four Star Major Airline by passengers, certified by the Airline Passenger Experience Association (APEX). The APEX Five Star and Four Star Airlines Awards are the only global awards based entirely on neutral, third-party passenger feedback. They are a result of passenger ratings of almost one million flights across nearly 600 airlines around the world, certified by APEX in partnership with TripIt® from Concur®. “Receiving this ratin. businesswire.com - 2 weeks ago
Accolade (ACCD) Loses -15.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Accolade (ACCD) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. zacks.com - 3 weeks ago
Accolade Welcomes Renalogic to Trusted Partner Ecosystem Partnership will drive cost savings for customers while providing high-touch services that improve health outcomes to members with chronic kidney disease (CKD).  SEATTLE , Oct. 15, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) today announced that Renalogic, the recognized industry leader that manages the human and financial costs of chronic kidney disease (CKD) for self-insured employers and their members, will join the company's Trusted Partner Ecosystem, to offer its proven CKD risk management and dialysis cost containment solutions. prnewswire.com - 1 month ago
Accolade (ACCD) Upgraded to Buy: Here's What You Should Know Accolade (ACCD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). zacks.com - 1 month ago
Accolade, Inc. (ACCD) Q2 2025 Earnings Call Transcript Accolade, Inc. (NASDAQ:ACCD ) Q2 2025 Earnings Conference Call October 8, 2024 8:00 AM ET Company Participants Todd Friedman - Senior Vice President of Investor Relations Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer Conference Call Participants Dan Clark - Leerink Partners Craig Hettenbach - Morgan Stanley Jailendra Singh - Truist Securities Jeff Garro - Stephens Inc. Richard Close - Canaccord Genuity Jessica Tassan - Piper Sandler Jared Haase - William Blair Stephanie Davis - Barclays Allen Lutz - Bank of America Ryan MacDonald - Needham & Company Stan Berenshteyn - Wells Fargo David Larsen - BTIG Jack Wallace - Guggenheim Operator Ladies and gentlemen, thank you for standing by. Welcome to Accolade Second Quarter 2025 Earnings Results Conference Call. seekingalpha.com - 1 month ago
Accolade (ACCD) Reports Q2 Loss, Tops Revenue Estimates Accolade (ACCD) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to loss of $0.43 per share a year ago. zacks.com - 1 month ago
Accolade Inc (ACCD) Q2 Earnings: Revenue Hits $106.4M, Beating Estimates; GAAP EPS Loss at $0.30 On October 8, 2024, Accolade Inc (ACCD, Financial) released its 8-K filing detailing the financial results for the fiscal second quarter ending August 31, 2024. Accolade Inc, a company offering technology-enabled solutions to navigate the healthcare system, reported a revenue of $106.4 million, exceeding the analyst estimate of $105.01 million. gurufocus.com - 1 month ago
Accolade Announces Results for Fiscal Second Quarter 2025 SEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2024. globenewswire.com - 1 month ago
Accolade Inc (ACCD) Q2 2025: Everything You Need to Know Ahead of Earnings Accolade Inc (ACCD, Financial) is set to release its Q2 2025 earnings on Oct 8, 2024. The consensus estimate for Q2 2025 revenue is $105.01 million, and the earnings are expected to come in at -$0.44 per share. gurufocus.com - 1 month ago
Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings Accolade, Inc. ACCD will release earnings results for its second quarter, before the opening bell on Tuesday, Oct. 8. benzinga.com - 1 month ago
Accolade to Announce Fiscal Second Quarter 2025 Financial Results SEATTLE, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2025 financial results on Tuesday, October 8, 2024 before market open. In conjunction, the company will host a conference call to review results at 8:00 a.m. E.T. on the same day. globenewswire.com - 1 month ago
8. Profile Summary

Accolade, Inc. ACCD

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 279 M
Dividend Yield 0.00%
Description Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Contact 660 West Germantown Pike, Plymouth Meeting, PA, 19462 https://www.accolade.com
IPO Date July 1, 2020
Employees 2400
Officers Ms. Kristin Herrera Executive Vice President and GM of Health Plan & Expert Medical Opinion Business Mr. Todd Friedman Senior Vice President of Investor Relations Mr. Colin McHugh Chief Accounting Officer Mr. Robert Cavanaugh President Mr. Stephen H. Barnes CPA Chief Financial Officer & Treasurer Ms. Kristen Bruzek Senior Vice President of Operations Mr. Rajeev Singh Chairman of the Board & Chief Executive Officer Ms. Kelsi McDonald Harris Chief People Officer & Senior Vice President Dr. Shantanu Nundy M.B.A., M.D. Executive Vice President, Chief Health Officer & Member of the Medical Advisory Board Mr. Drew Garner Executive Vice President of Engineering